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Abstract
Introduction: We report a case highlighting the multidisciplinary management of a giant pleomorphic adenoma
of the parotid gland that showed rapid growth in the third trimester of pregnancy.
Case presentation: A 43-year-old Caucasian woman presented in her 32nd week of gestation with a tumor of the
parotid gland. Ultrasonography of her neck showed a parotid lesion of 40 × 30 × 27.5 mm. A follow-up magnetic
resonance imaging scan of the neck four weeks later revealed that the tumor had grown to 70 × 60 × 60 mm,
reaching the parapharyngeal space with marked obstruction of the oropharynx of about 50%. After discussing the
case with our multidisciplinary tumor board and the gynecologists it was decided to deliver the baby by caesarean
section in the 38th week of gestation, and then to perform a surgical resection of the tumor.
Conclusion: Indications for early surgical intervention of similar cases should be discussed on an individual patient
basis in a multidisciplinary setting.
Introduction
With an incidence of 65%, pleomorphic adenoma is the
most common tumor of the salivary glands [1], and 80%
of the pleomorphic adenomas are located in the parotid
gland. These tumors are characterized by slow growth
over a period of years, and tend to remain asympto-
matic. In 4% of cases, they turn into malignant tumors.
In the following case report, we describe a pleomorphic
adenoma of the parotid gland that showed rapid growth
within the third trimester of pregnancy.
Case presentation
A 43-year-old Caucasian woman presented in her 32nd
week of gestation with a tumor of the parotid gland. She
had noticed the swelling increasing over the past six
months. She was otherwise asymptomatic, without any
pain, mouth-opening difficulties or facial nerve dysfunc-
tion. Ultrasonography of her neck showed a parotid
lesion 40 × 30 × 27.5 mm in size, with an heterogeneous
appearance. Considering her advanced state of preg-
nancy, we advised conservative management in the form
of watchful waiting and regular review until the birth.
At our patient’s next review, only five weeks later, we
noticed rapid growth of the lesion with expansion into the
parapharyngeal space. There was still no facial nerve invol-
vement, although our patient’s mouth opening was slightly
limited. Magnetic resonance imaging (MRI) of the neck
showed that the tumor had increased to 70 × 60 × 60 mm,
reaching the parapharyngeal space with marked obstruc-
tion of the oropharynx of about 50% (Figures 1, 2). Further
diagnostic tests such as fine-needle aspiration cytology
(FNAC) were discussed. We were concerned about the
risk of malignancy and increasing local complications due
to the rapid growth. Considering the risk of spreading
tumor cells and the unreliability of FNAC in identifying
the malignant nature of parotid carcinoma [2], we decided
to perform surgical resection to prevent further complica-
tions and to obtain a secure diagnosis.
After discussing this case with the gynecologists at our
interdisciplinary tumor board meeting, it was decided to
deliver the baby by caesarean section in the 38th week
of gestation with epidural anesthesia using mepivacain
and sufentanil. The surgical resection of the tumor was
performed four days later. It was possible to completely
remove the tumor via a standard cervicofacial incision
without the need to resect the mandible. Although the
tumor had stretched the facial nerve to double its usual
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(House Brackmann grade I).
On histological analysis, the lesion was identified as a
pleomorphic adenoma without evidence of malignancy
(Figure 3). Immunohistochemistry did not show any
positive expression of oestrogen or progesterone
receptors. Our patient remained well with no evidence
of recurrence after a follow-up of one year.
Discussion
The incidence of head and neck cancers during pregnancy
is rising [3]. Pleomorphic adenomas are characterized by
slow growth over a term of several years. Rapid increase or
the appearance of facial nerve dysfunction may indicate
malignant transformation, which has been reported in 4%
of cases. Rapid growth during the third trimester of preg-
nancy may indicate a possible hormonal influence on pleo-
morphic adenomas. A scientifically based relationship is
n o tp r o v e n[ 4 - 8 ] .T h e r em a yb eap r o g n o s t i ca s s o c i a t i o n
between the expression of progesterone receptors and
recurrent pleomorphic adenoma of the parotid gland [9].
Although in this case described here, we could not estab-
lish such a relationship, it is possible that unknown factors
(e.g. insulin-like growth factor, vascular endothelial growth
factor human placental lactogen).are released by the feto-
placental unit, and that these stimulate growth in other
end organs such as the parotid
Conclusion
We recommend frequent monitoring of tumors of the
salivary glands diagnosed during pregnancy. Indications
for early surgical intervention should be discussed on a
individual patient basis in a multidisciplinary setting.
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Figure 1 A coronal T2-weighted MRI of the head and neck
region (36th week of pregnancy). The left parotid mass is seen
distorting the pharynx. The outline of the heterogeneous lesion is
clearly demarcated, and tissue planes preserved.
Figure 2 An axial T2-weighted MRI of the head and neck
region (36th week of pregnancy). The outline of the
heterogeneous left parotid lesion is again clearly demarcated and
tissue planes preserved. The oropharyngeal lumen is distorted.
Figure 3 Pleimorphic adenoma without evidence of malignancy
(hematoxylin and eosin, original magnification × 100).
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